Founded with the mission to revolutionize interventional pain management, PainTEQ focuses on providing innovative solutions for chronic sacroiliac (SI) joint pain. The company's core product, the LinQ® SI Joint Stabilization System, offers a minimally invasive procedure designed to be performed in an outpatient setting, ensuring faster recovery times and avoiding the use of metal implants. PainTEQ aims to deliver safe, effective, and reproducible procedures based on data-driven outcomes and clinical research, targeting the interventional pain and spine specialist market.
PainTEQ has garnered attention from notable figures in the medical community and investors committed to advancing pain management technologies. The company has achieved significant milestones, including widespread adoption of the LinQ® procedure and positive clinical outcomes that underscore its efficacy. PainTEQ's impact is evident in its contribution to improving the quality of life for patients suffering from chronic SI joint pain, positioning itself as a leader in the SI Joint Dysfunction space.
